Perseus Proteomics Inc. (TYO:4882)

Perseus Proteomics Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 28, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	2,333	3,311	10,849	3,951	3,504	4,892
Market Cap Growth	-59.86%	-69.48%	174.57%	12.75%	-28.37%	-
Enterprise Value	818	2,075	8,970	2,288	893	1,523
Last Close Price	155.00	220.00	736.00	334.00	298.00	416.00
PS Ratio	17.28	24.53	90.41	39.51	37.28	68.90
PB Ratio	1.92	2.72	7.58	2.83	1.46	1.55
P/TBV Ratio	1.92	2.72	7.58	2.83	1.46	1.55
EV/Sales Ratio	6.06	15.37	74.75	22.88	9.50	21.45
Net Debt / Equity Ratio	-1.25	-1.25	-1.16	-1.10	-1.02	-1.02
Net Debt / EBITDA Ratio	2.04	2.04	2.02	1.73	3.53	6.82
Net Debt / FCF Ratio	2.29	2.29	2.10	1.58	3.36	6.31
Asset Turnover	0.08	0.08	0.07	0.05	0.03	0.03
Inventory Turnover	3.17	3.17	3.56	3.71	2.33	2.50
Quick Ratio	24.11	24.11	14.02	12.69	22.47	22.02
Current Ratio	24.74	24.74	14.32	12.89	22.65	22.23
Return on Equity (ROE)	-54.21%	-54.21%	-63.89%	-58.20%	-28.33%	-28.29%
Return on Assets (ROA)	-27.06%	-27.06%	-29.41%	-26.27%	-14.85%	-13.38%
Return on Capital Employed (ROCE)	-47.80%	-47.80%	-48.80%	-57.20%	-28.40%	-15.00%
Earnings Yield	-30.78%	-21.69%	-8.33%	-27.94%	-22.43%	-12.25%
FCF Yield	-28.38%	-19.99%	-7.32%	-24.70%	-20.77%	-10.41%
Buyback Yield / Dilution	-4.47%	-4.47%	-21.05%	-0.24%	-6.94%	-57.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.